Healthcare >> Analyst Interviews >> September 17, 2004

INVESTING IN BIOTECHNOLOGY: LIBBE ENGLANDER – BIOPHARMA CAPITAL

LIBBE ENGLANDER is a Senior Portfolio manager for BioPharma Capital, a European healthcare fund management company owned by IT Asset Management, a subsidiary of Raymond James. Dr. Englander co-manages ITAM's mutual fund that invests primarily in late stage US biotechnology companies. She co-founded BioPharma Capital in 2000. Prior to this, she founded EME Biology, a consulting firm that provided information and strategic planning services to the biotech industry. She has a PhD from Rockefeller University and a BS in Biology from Yale. Profile
TWST: Would you start us off with a quick overview of Biopharma Capital?

Dr. Englander: BioPharma Capital is a European healthcare fund

management company owned by IT Asset Management, a